Back

GIP and GLP-1 agonists for obesity

31 August 2024 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: When the diet does not work: pharmacological options for obesity Antidiabetic Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Chim Choy Lang

University of Dundee, Dundee (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
SGLT2 inhibitors for obesity
Professor J. Eriksson (Uppsala, SE)
Slides Video
Presentation thumbnail
Impact of obesity on other drug therapy
Professor B. Rocca (Casamassima, IT)
Slides Video
Presentation thumbnail
Patient perspective on treatment of obesity
Mr R. Stephens (Stevenage, GB)
Slides Video
Presentation thumbnail
When the diet does not work: pharmacological options for obesity - discussion
Video

Access the full session

Session thumbnail
When the diet does not work: pharmacological options for obesity
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 08:15 CET
You may be interested in
thumbnail
Congress Session
Targeting cardiovascular risk factors with GLP-1 RAs in people with obesity
27 August 2022
thumbnail
Congress Presentation
GLP-1 receptor agonist (GLP-1 RA) and gastric inhibitory polypeptides (GIPs) in HFpEF
30 August 2025
thumbnail
Congress Presentation
How has the concept of incretin mimetics evolved since SELECT?
31 August 2025
thumbnail
Congress Presentation
The next decade in the treatment of obesity
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources